Karin I. Eklind - Concepedia

Author

Karin I. Eklind

Institute for Cancer Prevention

Also Known As

K I Eklind, K. I. EKLIND, K.I. Eklind, Karin I. Eklind

Publications

956

Citations

H-Index

Concepts

All Affiliations

Institute for Cancer Prevention Dana (United States)National Institutes of Health

About

Karin I. Eklind is an author at Institute for Cancer Prevention specializing in medicine, pharmacology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	663
2	Biochemistry	5	5	567
3	Metabolism	3	3	333
4	Health Sciences	1	1	161
5	Allergy	1	1	37

Karin I. Eklind

Publications

895

Citations

H-Index

Page 1

	Year	Citations
Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Fung‐Lung Chung, Mark A. Morse, Karin I. Eklind, PubMed NutritionChemoprevention StrategyDietary ExposurePathologyAnticarcinogen Phenethyl Isothiocyanate	1993	161
Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. Mark A. Morse, Karin I. Eklind, Stephen S. Hecht, PubMed Chemoprevention StrategyDna MethylationPharmacotherapyPharmaceutical ChemistryTumor Biology	1991	137
Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice Zuyu Guo, Theresa J. Smith, Erjia Wang, Carcinogenesis	1993	122
Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates Mark A. Morse, Karin I. Eklind, Shantu Amin, Carcinogenesis	1989	110
Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Karin I. Eklind, Chang‐In Choi, Dhimant Desai, PubMed Inhibitory ActivityBiochemistryOncogenic AgentMedicineA/j Mice	1994	97
Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats Mark A. Morse, Karin I. Eklind, Mary Toussaint, Carcinogenesis Metabolomic ProfilingSecondary MetaboliteExperimental PharmacologyGlucuronide MetabolitePharmacological Study	1990	89
Distribution and metabolism of the natural anticarcinogen phenethyl isothiocyanate in A/J mice Karin I. Eklind, Mark A. Morse, Fung‐Lung Chung Carcinogenesis Maximum RadioactivityRadioactivity PresentBiochemistryOncogenic AgentMedicine	1990	83
New potential chemopreventive agents for lung carcinogenesis of tobacco-specific nitrosamine Fung‐Lung Chung, Mark A. Morse, Karin I. Eklind Lung Cancer OncologyChemoprevention StrategyNitrosative StressMedicineLung Carcinogenesis	1993	41
Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice Mark A. Morse, Karin I. Eklind, Shantu Amin, Cancer Letters AllergyLung InflammationMedicineRespiratory ToxicologyA/j Mice	1992	37
A/J Mouse Lung Tumorigenesis by the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Its Inhibition by Arylalkyl Isothiocyanates Stephen S. Hecht, Mark A. Morse, Karin I. Eklind, Experimental Lung Research Arylalkyl IsothiocyanatesChain LengthMedicineRespiratory ToxicologyTobacco-specific Nitrosamine 4-	1991	18

Page 1